Comparing planned versus ad hoc coronary microvascular assessment: Ear... sciencedirect.com/science/articl…

Is there additional value in adding Impella to veno-arterial extracorp... sciencedirect.com/science/articl…

Exploring the interplay between coronary microvascular dysfunction and... sciencedirect.com/science/articl…

Coronary microvascular dysfunction and inflammation: Insights from the... sciencedirect.com/science/articl…

Just published in CRMjournal Interesting Cases! We describe primary closure of the aorto-caval tract after #transcaval #TAVR with a covered stent in a small sized abdominal aorta. bit.ly/3ypOyYo Ilan Merdler Lior Lupu BCaseMD Ron Waksman Itsik Ben Dor #TobyRogers

Temporal trends with the Evolut family of self‐expanding transcatheter heart valves: A single‐center experience - Merdler - Catheterization and Cardiovascular Interventions - Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/cc…

Just published in CircInterventions: Our State-of-the-Art Review on Bioprosthetic #Aortic #Valve Thrombosis, in which we discuss the incidence, mechanisms, diagnosis, and management of subclinical and clinical leaflet #thrombosis. bit.ly/4bSGDlg #cardiotwitter #YesCCT #TAVR

The 2nd episode of “The Fellows’ Call” is now out, where we discuss the need for an abbreviated duration and more efficient pathways of training in medicine subspecialities ✨ Check out the link 👉🏻 rb.gy/u5the6 & let us know what you think! #CardioTwitter #ACCFIT

Just accepted in CRMjournal+Elsevier Cardiology! Impact of #LBBBor permanent #PPM after #TAVR #TAVI on mid-term #LVEF by Ilan Merdler BCaseMD Kalyan Chitturi Itsik Ben Dor ron waksman et al. clinicalkey.com/#!/content/pla…

PROTECT IV is enrolling high-risk PCI with or without Impella with a sample size estimate of 1252 patients. Our center's 2-year outcome is 30.8 %, we estimate that PROTECT IV requires 1966 patients, demonstrating that PROTECT IV is probably underpowered. pubmed.ncbi.nlm.nih.gov/39013705/

Two‐year follow‐up of transcatheter aortic valve replacement in low‐risk patients with symptomatic severe bicuspid aortic valve stenosis - Merdler - Catheterization and Cardiovascular Interventions - Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/cc…

@ELS_Cardiology Aloke Finn @NHLBI_Translate Giorgio A. Medranda MD, FACC, FAHA, FSCAI Ilan Merdler Sukhdeep Bhogal Mohit Pahuja Anwar Chahal MD PhD MRCP Timothy Henry CRT Meeting

Our article on #CMD in Cancer Patients with #ANOCA, led by ⭐️Ilan Merdler, is now out in REC Publications, official journal of Soc Esp Cardiología 🎊 BCaseMD Hayder Hashim Ron Waksman Prof. Hector M. Garcia-Garcia Georgetown/WHC Cardiology Fellows Washington D.C. chapter, ACC CRT Meeting SCAI #CardioTwitter 🔗 rb.gy/zh4lzz

Does epicardial fat play a role in coronary microvascular dysfunction (CMD)? 🤔Our new study suggests a link between increased epicardial fat index and CMD. More studies needed, but our research could be a key to better CMD diagnosis & treatment! doi.org/10.1161/JAHA.1…

Published #JACCINT our global survey understanding the perspective of IC in regards to CFT. Overcoming misconceived barriers and performing uniform testing is still needed. Ilan Merdler Kalyan Chitturi Ron Waksman Hayder Hashim JACC Journals CRT Meeting doi.org/10.1016/j.jcin…

Action packed day at #CRT2025 discussing all our important work #CMD CRT Meeting Ilan Merdler Kalyan Chitturi, DO, FACC Ron Waksman Hayder Hashim Giorgio A. Medranda MD, FACC, FAHA, FSCAI Abhishek Chaturvedi MD

Check out our recent review on ACS and the burgeoning field of Cardio-Rheumatology pubmed.ncbi.nlm.nih.gov/40094966/ Thanks to Shaikh Iqbal Ilan Merdler BCaseMD

In this review will seek to highlight prior studies and future directions in the treatment of acute coronary syndrome in patients with rheumatologic disease. Great work by Ilan Merdler Andrew Hill Georgetown/WHC Cardiology Fellows MedStar Health